Prof. Dr. Reiner Jumpertz-von Schwartzenberg has accepted the appointment to the professorship for Clinical Metabolism and Obesity Research at the Faculty of Medicine in the summer semester of 2022. He studied medicine in Bochum and Leipzig, where he received his doctorate in 2012. During his subsequent stays abroad as a visiting scientist at the National Institute of Health (NIH) in the USA and the University of California/San Francisco, he deepened his research on obesity, diabetes and the gut microbiome. Since 2021, Jumpertz-von Schwartzenberg has been senior physician for diabetology, endocrinology and nephrology as well as head of the study centre of the Institute for Diabetes Research and Metabolic Diseases at the University Hospital Tübingen. He also leads a Helmholtz Young Investigator Group and is junior research group leader in the Cluster of Excellence "Controlling Microbes to Fight Infections" (CMFI) in Tübingen, where he investigates the mechanisms underlying the development of metabolic diseases. The focus is on the interactions between the gut microbiome and host metabolism in the context of intestinal food absorption.
Prof. Dr. Hannes Link is Professor for Bacterial Metabolomics at the University of Tübingen from October 2020. He studied Chemical-Engineering at the Technical University Munich from 2000-2005 and received his PhD from the Department of Biochemical Engineering of the TU Munich in 2009. After 5 years as a postdoc with Prof. Uwe Sauer at the ETH Zurich, he headed an Emmy Noether research group at the MPI for Terrestrial Microbiology in Marburg from 2015-2020. His research group investigates metabolic networks and interactions between metabolites and regulators of gene expression. The aim of his research is to engineer bacterial metabolism for biotechnological and medical applications. This work includes the development of metabolomics methods to quantify metabolites and metabolic fluxes.
Prof. Dr. Lisa Maier has been appointed to the professorship ‘Microbiome-Host Interactions’ at the Faculty of Medicine in April 2022. She completed her studies in biochemistry at the University of Tübingen (2004-2009) and her PhD in the laboratory of Wolf-Dietrich Hardt at ETH Zurich (2014). As part of the interdisciplinary postdoctoral program at EMBL in Heidelberg, she worked in the groups of Nassos Typas and Kiran Patil (2015-2018). In 2019, she returned to Tübingen as CMFI and Emmy Noether junior research group leader. Her lab uses automated high-throughput and multi-readout approaches to systematically study the lifestyle of bacteria in the human microbiome. The resulting datasets are then used as a starting point for mechanistic studies to uncover the molecular details of how the microbiome interacts with its host.